Top Markets
#1 龙虾 (Lobster) 龙虾 (Lobster) +64.00%
#2 SODAX SODAX +50.99%
#3 Cortex Cortex +32.55%
#4 DexNet DexNet +23.19%
#5 Pons Pons +20.53%
#6 Akedo Akedo +20.13%
#7 wojak wojak +18.06%
#8 OpenEden OpenEden +15.28%
#9 Orbs Orbs +14.71%
#10 APEX APEX +13.93%
Coin of the day
龙虾 (Lobster) 龙虾 (Lobster)
設定
言語
日本
通貨
USD
テーマ
Chinook Therapeutics, Inc. Chinook Therapeutics, Inc.

Chinook Therapeutics, Inc.

KDNY
株式のランク #7141
Chinook Therapeutics, Inc., a biotechnology enterprise in the clinical... Chinook Therapeutics, Inc., a biotechnology enterprise in the clinical development phase, is dedicated to the identification, progression, and market introduction of precise medical treatments for kidney-related conditions. The company's primary therapeutic candidate, atrasentan, is an endothelin receptor antagonist currently in Phase III clinical trials. This drug aims to treat IgA nephropathy and various other glomerular diseases characterized by proteinuria. Beyond its lead program, Chinook's investigational pipeline includes BION-1301, an anti-APRIL monoclonal antibody, which is presently being evaluated in a Phase I/II study for IgA nephropathy. Another promising candidate is CHK-336, an oral small molecule designed to inhibit LDHA, intended for patients with primary hyperoxaluria. The firm also maintains active research initiatives exploring solutions for other uncommon and severe chronic kidney ailments. Chinook Therapeutics, Inc. is based in Seattle, Washington.
株価
$40.39
最終同期: 2023-08-18
時価総額
$1.70B
変化（1日）
0.00%
変化（1年）
0.00%
国
US
取引 Chinook Therapeutics, Inc. (KDNY)

カテゴリー

Healthcare
Chinook Therapeutics, Inc.（KDNY）のP/B比率
2026 時点のP/B比率 TTM: 0
Chinook Therapeutics, Inc. の最新の財務報告および株価によると、現在のP/B比率（TTM）は 0 です。2026 年末時点でのP/B比率は 0 でした。
Chinook Therapeutics, Inc. の P/B 比率の履歴（2026 ～ 2026）
各年末時点のP/B比率
年 P/B比率 変化
提供された日付のデータは十分ではありません。
同業他社のP/B比率
企業 P/B比率 P/B比率の差 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 3.7087 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH